Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
CMPX
#2473
Compass Therapeutics, Inc. Common Stock
5.4
4
USD
+4.62%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+4.62%
Aylık Değişim
+3.62%
6 aylık değişim
+25.35%
Yıllık Değişim
+225.75%
Önceki Kapanış
5.2
0
Open
5.4
4
Bid
Ask
Low
5.4
4
High
5.4
4
Hacim
88
Piyasalar
ABD Borsası
Sağlık Hizmetleri
CMPX
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
52.11 M
101.3 M
126.51 M
137.59 M
138.28 M
180.09 M
—
Valuation ratios
Enterprise value
—
180.65 M
616.57 M
179.4 M
157.03 M
936.43 M
2.07 B
Price to earnings ratio
—
—
-13.81
-4.42
-4.03
-12.74
-30.9
Price to sales ratio
—
—
7 738.68
—
234.36
—
—
Price to cash flow ratio
—
—
-15.87
-4.63
-4.44
-17.23
-42.3
Price to book ratio
—
—
2.98
1.27
1.59
4.3
6.54
Enterprise value to EBITDA ratio
—
-2.17
-15.12
-3.61
-2.8
-12.91
-29.64
Profitability ratios
Return on assets %
-0.57
-0.53
-0.2
-0.27
-0.35
-0.3
-0.43
Return on equity %
-0.74
-0.59
-0.22
-0.29
-0.39
-0.34
-0.51
Return on invested capital %
-2 400.42
-3 895.2
-2 451.74
-3 972.63
-3 718.91
-3 106.31
—
Gross margin %
100
100
100
—
100
—
—
Operating margin %
9 932.86
-194.96 K
-59.51 K
—
-6 661.76
—
—
EBITDA margin %
9 175.71
-193.43 K
-58.26 K
—
-6 591.18
—
—
Net margin %
10.54 K
-195.67 K
-56.04 K
—
-5 808.82
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.97
13.84
12.05
19.73
14.96
15.02
48.83
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
-0.01
0
0
0
0.01
0
0
Solvency ratios
Debt to assets ratio
0.04
0.03
—
—
—
—
—
Debt to equity ratio
0.05
0.03
—
—
—
—
—
Long term debt to total assets ratio
0.04
0
—
—
—
—
—
Long term debt to total equity ratio
0.05
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-0.32
-0.32
-0.33
-0.31
-0.33
EBIT per share
—
—
-0.4
-0.4
-0.41
-0.46
-0.49
EBITDA per share
—
—
-0.39
-0.39
-0.41
-0.46
-0.49
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
1.77
1.2
0.92
1.32
4.17
Net current asset value per share
—
—
1.85
1.21
0.97
1.33
4.31
Tangible book value per share
—
—
1.73
1.17
0.91
1.25
3.96
Working capital per share
—
—
1.7
1.15
0.9
1.24
3.94
Book value per share
—
—
1.73
1.17
0.91
1.25
3.96
Haberler
Will Psychedelic Stocks Have A Trippy Ride Under RFK Jr.?
Stifel, Compass Therapeutics için hisse tavsiyesini yineledi
Citizens, Compass Therapeutics hissesi için görüşünü korudu
Compass Therapeutics stock rating reaffirmed at Citizens on trial progress
Jefferies, Compass Therapeutics için hisse hedefini yükseltti
Jefferies raises Compass Therapeutics stock price target on trial progress
Compass Therapeutics hissesi William Blair’de Outperform seviyesinde
Compass Therapeutics stock holds Outperform at William Blair ahead of trial data
Raymond James, Compass Therapeutics hissesi için Outperform notunu korudu
Raymond James reiterates Compass Therapeutics stock Outperform rating
Compass Therapeutics’in kritik kanser verileri yaklaşırken
Compass Therapeutics earnings on deck as pivotal cancer data looms